Shypd.aiThe largest open index of AI toolsHITS is an AI-driven biotech company that innovates drug discovery. It leverages AI to accelerate the development of new drugs, offering solutions for virtual screening, drug design, and ADME/T prediction.
Also listed in
About
HITS is an AI-driven biotech company focused on revolutionizing drug discovery through advanced artificial intelligence. Their platform, Hyper Lab, offers a suite of products including Hyper ADME/T for predicting drug properties, Hyper Design for novel molecule design, Hyper Binding for drug-protein interaction analysis, and Hyper Screening for efficient hit identification. HITS integrates physics-based modeling with deep learning to rapidly identify effective compounds and design new drug structures. The company aims to make AI-powered drug development accessible and efficient, reducing costs and accelerating the timeline from discovery to market.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check hits.ai for current pricing.
FAQs
